Estrogen Plus Progestin and Lung Cancer in Postmenopausal Women

BACKGROUND: In the post intervention period of the Women’s Health Initiative (WHI) clinical trial, estrogen plus progestin increased total cancer incidence and an adverse influence on lung cancer mortality was suggested. METHODS: We conducted post hoc analyses over the full follow-up period of the W...

Full description

Saved in:

Bibliographic Details
Main Authors:	Chlebowski, Rowan T., Schwartz, Ann G., Wakelee, Heather, Anderson, Garnet L., Stefanick, Marcia L., Manson, JoAnn E., Rodabough, Rebecca J., Chien, Jason W., Wactawski-Wende, Jean, Gass, Margery, Kotchen, Jane Morley, Johnson, Karen C., O’Sullivan, Mary Jo, Ockene, Judith K., Chen, Chu, Hubbell, F. Allan
Format:	Artigo
Language:	Inglês
Published:	2009
Subjects:	Article
Online Access:	https://ncbi.nlm.nih.gov/pmc/articles/PMC2995490/ https://ncbi.nlm.nih.gov/pubmed/19767090 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S0140-6736(09)61526-9
Tags:	Add Tag No Tags, Be the first to tag this record!

Estrogen Plus Progestin and Lung Cancer in Postmenopausal Women

Similar Items